City

Fuzhou (1)

Condition

Gastrict Cancer (1)

Immunotherapy (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Fujian Cancer Hospital (1)

Collaborator

Intervention

apatinib mesylate (1)

oxaliplatin (1)

tegafur (1)

tislelizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

gastrict cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting

Immunotherapy
Gastrict Cancer

Tislelizumab
+3 more

Fuzhou, China

Fujian cancer hospital

Jan 17, 2023